Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future
In the past 20 years, patients with rheumatoid arthritis (RA), Crohn's disease (CD), and other immune diseases have witnessed the impact of a great treatment advance with the availability of biological TNFα inhibitors. With 5 approved anti-TNFα biologics on the market and soon available biosimi...
Main Authors: | Hongtao Zhang, Nelson Shi, Zhuo Diao, Youhai Chen, Yejia Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304220300349 |
Similar Items
-
Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer
by: Isela Martínez-Reza, et al.
Published: (2017-12-01) -
Complexity of TNF-α Signaling in Heart Disease
by: Filip Rolski, et al.
Published: (2020-10-01) -
Phytochemicals against TNF<i>α</i>-Mediated Neuroinflammatory Diseases
by: Lalita Subedi, et al.
Published: (2020-01-01) -
Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches
by: Madhu Sudhana Saddala, et al.
Published: (2019-07-01) -
Anti-TNF-α Compounds as a Treatment for Depression
by: Sarit Uzzan, et al.
Published: (2021-04-01)